Medical Laboratory Management and Supervision

Por Berney, D M
Publicado em 1996

Public opinion on the use of tissue samples

Por Berney, D M
Publicado em 2004

Clear cell carcinoma of the ovary arising in a mucinous cystadenoma

Por Dutt, N, Berney, D
Publicado em 2000

Clear cell carcinoma of the ovary arising in a mucinous cystadenoma

Por McCluggage, W, Berney, D, Dutt, N
Publicado em 2001

Variations in the processing of prostatic needle cores in the UK; what is safe?

Por Biedrzycki, O, Varma, M, Berney, D M
Publicado em 2003

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

Por Powles, T, Shamash, J, Berney, D, Oliver, R T D
Publicado em 2003

Angiolymphoid hyperplasia with eosinophilia in the colon: a novel cause of rectal bleeding.

Por Berney, D M, Griffiths, M P, Brown, C L
Publicado em 1997

Technical variations in prostatic immunohistochemistry: need for standardisation and stringent quality assurance in PSA and PSAP immunostaining

Por Varma, M, Berney, D M, Jasani, B, Rhodes, A
Publicado em 2004

A case of insulin and ACTH co-secretion by a neuroendocrine tumour

Por Solomou, S, Khan, R, Propper, D, Berney, D, Druce, M
Publicado em 2014

Giardiasis of the stomach.

Por Berney, D. M., Rampton, D., van der Walt, J. D.
Publicado em 1994

DNA topoisomerase I and II expression in drug resistantgerm cell tumours

Por Berney, D M, Shamash, J, Gaffney, J, Jordan, S, Oliver, R T D
Publicado em 2002

Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?

Por Berney, D M, Shamash, J, Hendry, W F, Arora, A, Jordan, S, Oliver, R T
Publicado em 2001

Prediction of progression in pTa and pT1 bladder carcinomas with p53, p16 and pRb

Por Hitchings, A W, Kumar, M, Jordan, S, Nargund, V, Martin, J, Berney, D M
Publicado em 2004

Prognostic value of Ki-67 for prostate cancer death in a conservatively managed cohort

Por Fisher, G, Yang, Z H, Kudahetti, S, Møller, H, Scardino, P, Cuzick, J, Berney, D M
Publicado em 2013

Pure aldosterone-secreting adrenocortical carcinoma in a patient with refractory primary hyperaldosteronism

Por Hussain, S, Panteliou, E, Berney, D M, Carpenter, R, Matson, M, Sahdev, A, Bell, M, O'Sullivan, E, Drake, W M
Publicado no Endocrinol Diabetes Metab Case Rep (2015)

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours

Por Shamash, J, Powles, T, Ansell, W, Berney, D, Stebbing, J, Mutsvangwa, K, Wilson, P, Asterling, S, Liu, S, Wyatt, P, Joel, S P, Oliver, R T D
Publicado em 2007

Long-term outcome among men with conservatively treated localised prostate cancer

Por Cuzick, J, Fisher, G, Kattan, M W, Berney, D, Oliver, T, Foster, C S, Møller, H, Reuter, V, Fearn, P, Eastham, J, Scardino, P
Publicado em 2006

Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma

Por Bharwani, N, Miquel, M E, Powles, T, Dilks, P, Shawyer, A, Sahdev, A, Wilson, P D, Chowdhury, S, Berney, D M, Rockall, A G
Publicado em 2014

A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice

Por Newton, C., Murali, K., Ahmad, A., Hockings, H., Graham, R., Liberale, V., Sarker, S.-J., Ledermann, J., Berney, D.M., Shamash, J., Banerjee, S., Stoneham, S., Lockley, M.
Publicado no Eur J Cancer (2019)

The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer

Por Powles, T., Kayani, I., Blank, C., Chowdhury, S., Horenblas, S., Peters, J., Shamash, J., Sarwar, N., Boletti, K., Sadev, A., O'Brien, T., Berney, D., Beltran, L., Haanen, J., Bex, A.
Publicado em 2011